[高性心肌病:对诊断和治疗的新见解]
Luis E Gómez1, Andrés N Atamañuk1, Guillermo Jaimovich2
1División Cardiología, Hospital De Agudos Juan A. Fernández, Buenos Aires, Argentina.
Medicina
|November 28, 2025
概括
增高性心肌病变 (HCM) 是一种遗传性心脏病,每500人中就有1人受到影响. 诊断和向治疗的进步使得HCM成为一种可控的疾病,死亡率降低.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 医学诊断 医学诊断 医学诊断
背景情况:
- 增高性心肌病变 (HCM) 是一种普遍的遗传性心脏病,由左心室增高 (LVH) 定义.
- 它遵循自体主导遗传模式,经常涉及MYH7和MYBPC3基因.
- 在全球范围内,HCM影响着大约每500个人中就有1人.
研究的目的:
- 为了提供对缩性心肌病的全面概述.
- 讨论诊断方式,风险分层工具和管理策略.
- 突出最近的治疗进展和未来的研究方向.
主要方法:
- 诊断包括心声回声和心脏磁共振成像 (CMR).
- 风险分层利用HCM风险-SCD和HCM风险-儿童等模型.
- 管理策略是根据HCM表型 (阻塞性,非阻塞性) 和相关疾病 (如心房) 量身定制的.
主要成果:
- CMR提供了关于晚期加多增强,动脉瘤和微血管功能障碍的见解,与不良结果相关.
- 风险分层模型指导植入式心脏转换器除器 (ICD) 治疗决策.
- 治疗选择范围从药物治疗 (β阻断剂,通道阻断剂,肌酸酶抑制剂) 到干预程序 (肌肉切除术,隔膜切除术).
结论:
- 基因检测,成像和向治疗方面的重大进展使得与HCM相关的死亡率每年降低到0.5%.
- 人们越来越多地认为HCM是一种可管理的疾病.
- 未来的研究旨在推进精准医学,手术技术和HCM患者的医疗保健可用性.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
374
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374
Cardiomyopathy V: Interprofessional Care
314
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
314
Cardiomyopathy II: Dilated Cardiomyopathy
447
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
447
Cardiomyopathy IV: Restrictive Cardiomyopathy
431
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
431
Cardiomyopathy I: Introduction and Classification
479
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
479
Heart Failure II: Pathophysiology
685
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
685


